Genius Group Limited (AMEX:GNS) does about 8.75M shares in volume on a normal day but saw 162931923 shares change hands in Monday trading. The company now has a market cap of 65.28M USD. Its current market price is $4.71, marking an increase of 45.37% compared to the previous close of $3.24. The 52 week high reached by this stock is $36.75 whilst the lowest price level in 52 weeks is $0.30. The script in recent trading has seen the stock touch a high of $6.28 and a low of $2.80.
Genius Group Limited (GNS) has a 20-day trading average at $0.83 and the current price is -87.18% off the 52-week high compared with 1464.78% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.59. If we look at the stock’s price movements over the week, volatility stands at 93.09%, which decreases to 32.91% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 96.82 to suggest the stock is overbought.
The consensus objective for the share price is $19.00, suggesting that the stock has a potential upside of 75.21% over the period. The median price target is 75.47% away from the current levels at $19.20.
The current price level is 664.93%, 825.45%, and 22.62% away from its SMA20, SMA50, and SMA200 respectively, with the GNS price moving below the 50-day SMA on January 23. Genius Group Limited (GNS) stock is up 893.67% over the week and 1377.42% over the past month. Its price is 1325.98% year-to-date.
Expected sales for next quarter are $11 million, which analysts say will come at $37.49 million for the current fiscal year and next year at $47.19 million. In addition, estimates put the company’s current quarterly revenue at an average of $10.5 million.
To reach the target analysts have set, the stock logically needs to grow 75.21 percent from here.
Outstanding shares total 24.31M with insiders holding 51.19% of the shares and institutional holders owning 0.10% of the company’s common stock. The company has a return on investment of -60.30%. The forward price to earnings ratio is 157.00. Price to book ratio is 2.49 and price to sales ratio is 3.58.